These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12756754)

  • 1. Acute and chronic experimental infection processes caused by Yersinia pseudotuberculosis and evaluation of interleukin action on their development and outcome.
    Tseneva GY; Voskressenskaya EA; Simbirtsev AS; Shestakova IV; Demakova TE; Chmyr IA
    Adv Exp Med Biol; 2003; 529():177-9. PubMed ID: 12756754
    [No Abstract]   [Full Text] [Related]  

  • 2. [An experimental model of pseudotuberculosis infection in monkeys].
    Marakulin IV; Darmov IV; Pogorel'skiĭ IP; Drobkov VI; Pautov VN
    Biull Eksp Biol Med; 1994 Jul; 118(7):59-62. PubMed ID: 7919275
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system.
    Carnoy C; Loiez C; Faveeuw C; Grangette C; Desreumaux P; Simonet M
    Adv Exp Med Biol; 2003; 529():133-5. PubMed ID: 12756744
    [No Abstract]   [Full Text] [Related]  

  • 4. [INTESTINAL FAILURE AND YERSINIA PSEUDOTUBERCULOSIS TRANSLOCATION IN THE DEVELOPMENTOF EXPERIMENTAL GENERALIZED INFECTION].
    Chicherin IY; Pogorelky IP; Lundovskikh IA; Darmov IV; Gorshkov AS; Shabalina MR
    Eksp Klin Gastroenterol; 2016; (3):24-31. PubMed ID: 27301139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on aerosol Yersinia pseudotuberculosis infection of guinea-pigs.
    Velianov D; Nikolova S; Naĭdenski Kh; Raducheva T; Kŭsovski V; Grigoriev I; Ilieva L
    Acta Microbiol Bulg; 1993; 30():3-10. PubMed ID: 8285130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic necrotizing factor is an effective immunogen in a Yersinia pseudotuberculosis aerosol mouse model.
    Mou S; Cote CK; Worsham PL
    Adv Exp Med Biol; 2012; 954():179-81. PubMed ID: 22782762
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prophylaxis of the experimental pseudotuberculosis infection by immunization with porin from Yersinia pseudotuberculosis].
    Darmov IV; Marakulin IV; Pogorel'skiĭ IP; Novikova OD; Portniagina OIu; Solov'eva TF
    Biull Eksp Biol Med; 1999 Feb; 127(2):221-3. PubMed ID: 10095962
    [No Abstract]   [Full Text] [Related]  

  • 8. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
    Hudson KJ; Bouton AH
    Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and regulation of the Salmonella-like pmrF antimicrobial peptide resistance operon in Yersinia pseudotuberculosis.
    Marceau M; Sebbane F; Collyn F; Simonet M
    Adv Exp Med Biol; 2003; 529():253-6. PubMed ID: 12756767
    [No Abstract]   [Full Text] [Related]  

  • 10. Defensive function of phagocytes in pseudotuberculosis.
    Plekhova NG; Somova-Isachkova LM; Shubin FN
    Adv Exp Med Biol; 2003; 529():161-4. PubMed ID: 12756750
    [No Abstract]   [Full Text] [Related]  

  • 11. [The interleukin-1 content of the blood in patients with a pseudotuberculosis infection and opisthorchiasis].
    Chuĭkova KI; Bogdashin IV; Vasil'ev NV
    Med Parazitol (Mosk); 1992; (5-6):11-3. PubMed ID: 1299750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
    Tansini A; de Medeiros BM
    Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An analysis of the antibodies to the outer cell membrane proteins in Yersinia in the varying course of human pseudotuberculosis].
    Malov IV; Shurygina IA; Volchenko IuE
    Ter Arkh; 1994; 66(4):62-4. PubMed ID: 8016734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of T cells and gamma interferon in Yersinia pseudotuberculosis-derived mitogen (YPM)-induced toxicity in mice.
    Kano H; Ito Y; Matsuoka K; Iwata T; Saito H; Kohsaka T; Abe J
    Adv Exp Med Biol; 2003; 529():137-9. PubMed ID: 12756745
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Yersinia pseudotuberculosis infection].
    Takeda N
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):496-9. PubMed ID: 10088455
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of infections with wild and mutant Yersinia pseudotuberculosis strains in rabbit oral model.
    Najdenski H; Vesselinova A; Golkocheva E; Garbom S; Wolf-Watz H
    Adv Exp Med Biol; 2003; 529():117-20. PubMed ID: 12756740
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.
    Auerbuch V; Isberg RR
    Infect Immun; 2007 Jul; 75(7):3561-70. PubMed ID: 17420232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic phenomena in experimental rodentiosis. II. Cellular and humoral factors in immunity to infection with Yersinia pseudotuberculosis.
    Jakoniuk P
    Arch Immunol Ther Exp (Warsz); 1976; 24(1):85-92. PubMed ID: 769740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.